The data reported here show that surface vimentin enhances the invasive potential caused by the SARS-CoV-2 receptor binding domain (RBD) of the spike protein in monolayers of both non-tumorigenic (MCF-10a) and cancer (MCF-7) cells. This evidence concerns the gene VIM and cancer.